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PorB2/3 Protein 
Hybrid in Neisseria 
meningitidis
To the Editor: Class 2 and class 3 
porin (PorB) proteins are the major pro-
teins found in the outer membrane of 
Neisseria meningitidis (1); they func-
tion as porins, allowing the passage 
of small molecules through the outer 
membrane. PorB outer membrane pro-
teins are transmembrane proteins with 
8 predicted surface-exposed loops (I-
VIII), which vary in length and in ami-
no acid sequences. Several sequence 
analyses of these proteins have shown 
4 regions with a high level of amino 
acid variability in loops I, V, VI, and 
VII (variable regions [VRs] 1–4) (2). 
The extensive antigenic variability of 
these proteins forms the basis of the N. 
meningitidis serotyping scheme (3,4). 
These 2 classes of proteins are mutu-
ally exclusive, and they are expressed 
by alternate alleles (porB2 and porB3) 
at the porB locus (1).
All  N. meningitidis strains re-
ceived in the Spanish Reference Labo-
ratory for Neisseria are routinely sero-
typed by whole-cell ELISA (5) with a 
set of monoclonal antibodies (MAbs) 
provided by the National Institute 
for Biological Standards and Control 
(South Mimms, UK) that includes the 
following serotypes: 1 (MN3C6B), 2a 
(5D4–5), 2b (MN2C3B), 4 (5DC4-
C8G8), 14 (MN5C8C), 15 (8B5–5G9), 
and 21 (6B11F2B5). Those meningo-
cocci that appear as nonserotypeable 
(NT) are analyzed by sequencing the 
porB gene (6). In the case discussed 
here, in the sequencing of a NT strain, 
the porB gene showed an unusual se-
quence. 
This strain, isolated in Spain dur-
ing 2006, was recovered from the 
cerebrospinal  ﬂ  uid of a patient with 
meningococcal disease. The porB gene 
sequence shows VR1–4, which is ex-
clusive of PorB3 protein, and VR2-Eb, 
VR3–2ab, and VR4-Cc, which are typ-
ical of PorB2 (GenBank accession no. 
EF094023). A comparison of this new 
sequence with the available porB se-
quences in the Neisseria.org database 
(http://neisseria.org/nm/typing/porB) 
enabled a more detailed analysis of 
the fragments corresponding to porB3 
and porB2 found in this sequence. The 
fragment from nt 1 to 213 was iden-
tical to the porB3–193 allelic variant 
(VR1–4, VR2-Aa, VR3–7, VR4–14b), 
and the second part, with nt 233–972 
identical to porB2–99 (VR1-Dc, VR2-
Eb, VR3–2ab, VR4-Cc). The region 
of 214–232 nt is identical in the 3 
variants. Therefore, this is a true hy-
brid molecule, which appears to have 
arisen from recombinational events 
between porB2–99 and porB3–193 al-
leles. In fact, this ﬁ  nding has prompt-
ed the inclusion of a new family called 
porB2/3 hybrid in the Neisseria.org 
database to facilitate the collection of 
this type of porB sequences.
The most likely origin of the 
porB2/3  hybrid (4, Eb, 2ab, Cc) is 
the acquisition of DNA that encodes 
a VR1–4 sequence by a meningococ-
cus with a porB2–99 allelic variant. It 
is less likely that DNA encoding the 
porB VR2-Eb, VR3–2ab, and VR4-Cc 
sequences was acquired by a menin-
gococcus with the porB3–193 allelic 
variant because a longer fragment of 
DNA would have been transferred.
In spite of the presence of a 
VR1–4, which should be recognized 
by the set of MAbs used, this strain 
appeared as NT. A Western blot assay 
using MAb type 4 showed a good rec-
ognition epitope-MAb. Therefore, the 
failure of MAbs to identify this strain 
may have been due to the limited ac-
cessibility of the epitope because of the 
alteration of the PorB protein, which 
might be affecting its conformation. 
Once again, genetic characterization 
should be a preferred method over 
phenotypic characterization for typ-
ing meningococcal strains. Molecular 
characterization of NT strains in other 
laboratories might clarify the true fre-
quency of this event.
Intragenic recombination between 
porin genes of the same allelic family 
is likely occurring in nature because 
mosaic gene structure has been report-
ed in porB genes. However, porB2/3 
recombinants have never been previ-
ously found in the nature. Given the 
known ability of meningococci to 
be transformed by DNA from other 
strains, it is surprising that occurrence 
of genuine porB2/3 hybrids has not 
yet been documented. There is only a 
report of naturally occurring gonococ-
ci expressing a hybrid porB1a/porB1b 
(7) (PorB1a and PorB1b gonococcus 
porins, as in meningococci, are encod-
ed by 2 families of diverged alleles of 
the porB gene [8]). Gonoccocal strains 
expressing the recombinant por genes 
appear to be particularly susceptible to 
the bactericidal effect of human serum 
(9). A similar situation might happen 
in  N. meningitidis, with a selective 
disadvantage in the invasive process 
of these hybrid strains, explaining the 
rarity of naturally occurring hybrids. 
By contrast, mechanisms like this are 
frequently used by meningococci to 
avoid the immune response against or-
dinary antigens. The balance between 
advantages and disadvantages at this 
level would show the true implications 
of this event.
This ﬁ  nding is relevant regardless 
of its frequency in nature. This report 
suggests how frequent the recombi-
nation events should occur among 
the meningococcal population: even 
theoretical mutually exclusive genes 
can produce hybrid variants; such 
knowledge is an important step in the 
development of future vaccines based 
on protein formulations.
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West Nile Virus in 
Birds, Argentina
To the Editor: West Nile virus 
(WNV), genus Flavivirus, family 
Flaviviridae has been rapidly dispers-
ing through the Americas since its in-
troduction in 1999 in New York (1). 
By 2004, serologic studies detected 
WNV-speciﬁ  c antibodies in birds and 
horses from Canada to northern South 
America (2–4). The ﬁ   rst report of 
WNV activity in the Southern Cone of 
South America surfaced in April 2006, 
when 3 horses died in Argentina (5). 
However, established transmission 
foci in Argentina are unknown. We re-
port evidence for the introduction and 
establishment of WNV in Argentina as 
early as January 2005.
Serum samples from free-ranging 
birds were collected from 5 locations 
in Argentina and screened for generic 
ﬂ  avivirus antibodies by using a block-
ing ELISA with monoclonal antibody 
6B6C-1 (6). Positive serum specimens 
were further characterized by plaque- 
reduction neutralization test (PRNT). 
We identiﬁ  ed the etiologic agent re-
sponsible for the previous ﬂ  avivirus 
infection by using the following cri-
teria: 80% neutralization of reference 
virus (WNV NY99-4132 or an Argen-
tinean strain of St. Louis encephalitis 
virus [SLEV CbaAr4005]) in serum 
diluted at least 1:40 and 4-fold greater 
titer compared with the other virus. 
Overall, 474 (25.6%) of 1,845 
serum specimens from 117 bird spe-
cies collected from January to June 
2006 tested positive when using the 
blocking ELISA; 30% inhibition was 
the threshold for a positive test. SLEV 
infections were conﬁ  rmed in 105 birds 
by PRNT; WNV infections were con-
ﬁ  rmed in 43 birds. Anti-WNV anti-
body titers ranged from 40 to 2,560 
in birds collected as early as January 
2005 in Córdoba City and as late as 
June 2006 in Mar Chiquita (Table). 
Recent WNV activity was indicated 
by seroconversion in 3 banded rufous 
hornero in Córdoba City between 
January and March 2005. Although 
659 (1.5%) of serum samples were 
positive for SLEV, no WNV infec-
tion was detected in free-ranging birds 
collected in 2004. As early as January 
2005, WNV was detected in a sero-
conversion so we suspect WNV was 
introduced before 2005 at the end of 
2004 in all 5 sampling locations and in 
a variety of ecosystems: Córdoba, pe-
riurban (1.1%, 6/543); Mar Chiquita, 
thorn forest (5.1%, 16/313); Monte 
Alto, semidry chaco forest (9.8%, 
8/82); Montecristo, cropland (9.5%, 
2/21); and San Miguel de Tucumán, 
periurban yungas foothills (4.9%, 
12/227).
In 2006, WNV was isolated from 
equines in Buenos Aires province (5). 
WNV transmission to resident birds 
collected further north in Córdoba, 
Chaco, and Tucumán provinces was 
detected in 2005 and 2006. Our data 
suggest that WNV was introduced into 
Argentina before 2005 and maintained 
naturally in enzootic foci where nu-
merous bird species from many fami-
lies were exposed. Presumably, as in 
North America, locally abundant pas-
serine birds such as turdids (thrushes) 
are amplifying hosts. If common spe-
cies of the Furnariidae (a family ab-
sent from temperate North America) 
prove to be competent hosts, they 
could play an important role in WNV 
transmission in Argentina because 
of their frequent exposure to WNV. 
Twelve (12.5%) of 96 F. ruffus sam-
pled in 2005 and 2006 tested positive.
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